Correlates of protection efficacy induced by vaccinia virus-specific CD8+ T-cell epitopes in the murine intranasal challenge model

European Journal of Immunology

Volumn 39, Issue 3, 2009, Pages 717-722

  Moutaftsi, Magdalini ^a   Salek Ardakani, Shahram ^a   Croft, Michael ^a   Peters, Bjoern ^a   Sidney, John ^a   Grey, Howard ^a   Sette, Alessandro ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

CD8+ T cell epitopes; i.n. challenge model; Immunogenicity; Protection efficacy vaccinia virus

Indexed keywords

EPITOPE; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN; PEPTIDE VACCINE; VACCINIA VACCINE; VIRUS ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ANTIGEN RECOGNITION; ARTICLE; BINDING AFFINITY; C57BL 6 MOUSE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOREGULATION; INFECTION PREVENTION; MOUSE; NONHUMAN; POXVIRUS INFECTION; PRIORITY JOURNAL; VACCINATION; ANIMAL; C57BL MOUSE; IMMUNIZATION; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; METABOLISM; VACCINIA; VACCINIA VIRUS; VIROLOGY;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; IMMUNIZATION; MICE; MICE, INBRED C57BL; VACCINIA; VACCINIA VIRUS;

EID: 64049089071     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200838815     Document Type: Article

References (25)

1. Xu, R., Johnson, A. J., Liggitt, D. and Bevan, M. J., Cellular and humoral immunity against vaccinia virus infection of mice. J. Immunol. 2004. 172: 6265-6271.
2. + T cells are complementary and essential for natural resistance to a highly lethal cytopathic virus. J. Immunol. 2005. 175: 6829-6836.
3. Belyakov, I. M., Earl, P., Dzutsev, A., Kuznetsov, V. A., Lemon, M., Wyatt, L. S., Snyder, J. T. et al., Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses. Proc. Natl. Acad. Sci. USA 2003. 100: 9458-9463.
4. + T lymphocytes and macrophage subsets in the control of a generalized virus infection. J. Virol. 1996. 70: 8301-8309.
5. *0201-restricted T cells and comparative analysis of smallpox vaccines. Proc. Natl. Acad. Sci. USA 2003. 100: 217-222.
6. + T-cell peptide epitope of vaccinia and variola viruses. J. Virol. 2004. 78: 7052-7060.
7. + T cell determinants to enable rational design and characterization of smallpox vaccines. J. Exp. Med. 2005. 201: 95-104.
8. Yewdell, J. W. and Bennink, J. R., Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu. Rev. Immunol. 1999. 17: 51-88.
9. Moutaftsi,M., Peters, B., Pasquetto, V., Tscharke, D. C., Sidney, J., Bui, H. H., Grey, H. and Sette, A., A consensus epitope prediction approach identifies the breadth of murine T(CD81)-cell responses to vaccinia virus. Nat. Biotechnol. 2006. 24: 817-819.
10. Oseroff, C., Kos, F., Bui, H. H., Peters, B., Pasquetto, V., Glenn, J., Palmore, T. et al., HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation. Proc. Natl. Acad. Sci. USA 2005. 102: 13980-13985.
11. *0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products. J. Immunol. 2005. 175: 5504-5515.
12. Bronte, V., Carroll, M. W., Goletz, T. J., Wang, M., Overwijk, W. W., Marincola, F., Rosenberg, S. A. et al., Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine. Proc. Natl. Acad. Sci. USA 1997. 94: 3183-3188.
13. Chahroudi, A., Chavan, R., Kozyr, N., Waller, E. K., Silvestri, G. and Feinberg, M. B., Vaccinia virus tropism for primary hematolymphoid cells is determined by restricted expression of a unique virus receptor. J. Virol. 2005. 79: 10397-10407.
14. Liu, L., Xu, Z., Fuhlbrigge, R. C., Pena-Cruz, V., Lieberman, J. and Kupper, T. S., Vaccinia virus induces strong immunoregulatory cytokine production in healthy human epidermal keratinocytes: A novel strategy for immune evasion. J. Virol. 2005. 79: 7363-7370.
15. + T cells by infected dendritic cells in vivo. Nat. Immunol. 2002. 3: 265-271.
16. Drillien, R., Spehner, D., Bohbot, A. and Hanau, D., Vaccinia virus-related events and phenotypic changes after infection of dendritic cells derived from human monocytes. Virology 2000. 268: 471-481.
17. Engelmayer, J., Larsson, M., Subklewe, M., Chahroudi, A., Cox, W. I., Steinman, R. M. and Bhardwaj, N., Vaccinia virus inhibits the maturation of human dendritic cells: A novel mechanism of immune evasion. J. Immunol. 1999. 163: 6762-6768.
18. Jenne, L., Hauser, C., Arrighi, J. F., Saurat, J. H. and Hugin, A.W., Poxvirus as a vector to transduce human dendritic cells for immunotherapy: Abortive infection but reduced APC function. Gene Ther. 2000. 7: 1575-1583.
19. Crowe, S. R., Miller, S. C. andWoodland, D. L., Identification of protective and non-protective T cell epitopes in influenza. Vaccine 2006. 24: 452-456.
20. + T cell immunodominance in primary and secondary influenza virus infections. J. Exp. Med. 2003. 198: 399-410.
21. Botten, J., Whitton, J. L., Barrowman, P., Sidney, J., Whitmire, J. K., Alexander, J., Ting, J. P. et al., HLA-A2-restricted protection against lethal lymphocytic choriomeningitis. J. Virol. 2007. 81: 2307-2317.
22. Assarsson, E., Greenbaum, J. A., Sundstrom, M., Schaffer, L., Hammond, J. A., Pasquetto, V., Oseroff, C. et al., Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes. Proc. Natl. Acad. Sci. USA 2008. 105: 2140-2145.
23. Cochran, M. A., Puckett, C. and Moss, B., In vitro mutagenesis of the promoter region for a vaccinia virus gene: Evidence for tandem early and late regulatory signals. J. Virol. 1985. 54: 30-37.
24. + T cells shapes the immunodominance hierarchy during boost vaccination. J. Exp. Med. 2007. 204: 2187-2198.
25. *0201-restricted, Hepatitis C Virus-derived epitopes for cytotoxic T lymphocytes. Viral Immunol. 2006. 19: 458-467.